Back to results
US 2003/0072802 A1Published application
Sustained release topiramate
AssigneeR.T. Alamo Ventures, Inc.
InventorNeal R. Cutler
Life of this patent
Estimating the term…
Abstract
The present invention is an improvement in the treatment of mania and depression by administering topiramate in a sustained-release formulation. The sustained-release formulation of the present invention may also be co-administered with anti-psychotics and anti-depressants.
Claims9
A sustained-release formulation comprising topiramate.
A method of treatment comprising:
- a) providing i) a patient displaying one or more symptoms of mania and ii) a sustained-release formulation comprising topiramate;
- b) administering said formulation to said patient under conditions such that said one or more symptoms of said mania is reduced.
A method of treatment, comprising:
- a) providing, i) a patient exhibiting one or more symptoms of depression and ii) a sustained-release formulation comprising topiramate;
- b) administering said formulation to said patient under conditions such that said one or more symptoms of said depression is reduced.
The method of claim 7 wherein, said topiramate is co-administered with an anti-depressant.
A method of treatment, comprising:
- a) providing, i) a patient exhibiting one or more symptoms of bipolar disorder and ii) a sustained-release formulation comprising topiramate;
- b) administering said formulation to said patient under conditions such that said one or more symptoms of said bipolar disorder is reduced.
The method of claim 10 wherein, said topiramate is co-administered with an anti-psychotic.
Dependencies are inferred from the claim text.